.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The emergence of extensively drug-resistant (XDR) typhoid has created a major therapeutic challenge in South Asia. Randomized evidence comparing azithromycin with more intensive antibiotic strategies in uncomplicated enteric fever has helped define when oral therapy remains reasonable and when resistant disease requires escalation. The key clinical issue is not simply selecting an antibiotic but obtaining susceptibility information when feasible, recognizing treatment failure early and understanding local resistance patterns. For physicians in endemic settings, persistent fever, prior antibiotic exposure and epidemiologic context should raise concern for resistant infection. Laboratory confirmation and blood culture remain important whenever possible because empiric use of broad-spectrum agents can accelerate antimicrobial resistance. The management of typhoid also highlights the role of prevention through vaccination, sanitation and safe food and water. The broader message for APICON is that “guidelines versus realities” becomes particularly important in infectious disease: recommendations are only effective when diagnostic capacity, antimicrobial stewardship and local epidemiology are incorporated into clinical decision-making.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The emergence of extensively drug-resistant (XDR) typhoid has created a major therapeutic challenge in South Asia. Randomized evidence comparing azithromycin with more intensive antibiotic strategies in uncomplicated enteric fever has helped define when oral therapy remains reasonable and when resistant disease requires escalation. The key clinical issue is not simply selecting an antibiotic but obtaining susceptibility information when feasible, recognizing treatment failure early and understanding local resistance patterns. For physicians in endemic settings, persistent fever, prior antibiotic exposure and epidemiologic context should raise concern for resistant infection. Laboratory confirmation and blood culture remain important whenever possible because empiric use of broad-spectrum agents can accelerate antimicrobial resistance. The management of typhoid also highlights the role of prevention through vaccination, sanitation and safe food and water. The broader message for APICON is that “guidelines versus realities” becomes particularly important in infectious disease: recommendations are only effective when diagnostic capacity, antimicrobial stewardship and local epidemiology are incorporated into clinical decision-making.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
